Infinite Dose PRO Calculator

62
Infinite Dose PRO Calculator is an Android app from MOANESS in the Medical category, currently rated 4.5★ across 265 ratings. Initial signal reads as largely positive sentiment, users highlighting consistency and feature depth.
Quality Score is 62: Solid (established niche player). For a Medical app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Medical complexity ×1.55 | +$27K |
| 🌐 Cross-platform reach (iOS + Android) | +$43K |
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 📺 Ad-supported base | 15× MRR |
| ⭐ ★ rating ≥ 4.4 (solid) | +8% |
| 🏷 Medical category multiple | +12% |
| ⭐ Small user base (<1K ratings) | -8% |
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
| 📲 Medical engagement | ~55 installs / rating |
| 🔁 Medical D30 retention | 25% |
| 📍 DAU / MAU stickiness | 0.20 |
How we forecast this revenue
MEDIUM CONFIDENCEBU Investment Matrix
Early-stage solo · 46/100INDIE TIERexpected for tier- 💰 Revenue: Modest — $1K - $11K/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.48★ across 265 reviews — solid.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL| Paid app ($9.99)METRIC | +$2,800 | |
| 5 starREVIEW | +$1,800 | |
| excellent appREVIEW | +$1,500 | |
| Mature app (9y old)METRIC | +$1,500 | |
| Good rating (4.5★)METRIC | +$800 | |
| Early-stage install base (265 ratings)METRIC | +$400 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- Infinite Dose PRO Calculator
- Developer
- MOANESS
- Bundle ID
- com.moaness.InfiniteDose.pro
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- Infinitedose.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Reported revenue signal / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $362/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📝 About this app
A must-have drug dosing app for every physician or nurse to calculate the most challenging intravenous Emergency, ICU, and NICU drug doses or simply the simplest pediatric outpatient daily oral medications.
Whether you are a Registered Nurse, Pediatrician, Anesthesiologist, Intensivist, General Practitioner, or any health professional, <b>this app is for you.</b>
<b>Overview of features:</b>
✓ Easy Drug Dosage Calculator. Just Drag The Seek Bar.
✓ Easy Drug IV Infusion Calculator (IV Rate in mL/hour or Drops Rate/min)… View full description on the official store →
Track this app’s revenue
FREE📝 Description
95
More by MOANESS
View all →Why medium confidence: 265 ratings · no founder-verified revenue (model estimate only).



